Aseptuva

🌟 November Highlights for Aseptuva 🌟 The last month has been nothing short of transformative for Aseptuva, as we took our mission against hospital infections across the Atlantic to the #US! 🌍✈️ We were on the ground, engaging with stakeholders, healthcare experts, and potential partners, while evaluating potential sites for future #US operations. Here's a quick recap of our journey: ✅ Massachusetts Through the Venture Leaders Medtech program by Venturelab, we connected with leading hospitals and investors, gaining invaluable insights into the healthcare ecosystem. ✅ Texas Exploring Houston and Austin, we were amazed by the resources and opportunities at the Texas Medical Center. Productive discussions with doctors and experts highlighted the region’s vibrant #Medtech community. Furthermore, MBA students at Texas McCombs School of Business undertook an in-depth evaluation of our US strategy as part of their McCombs+ project. ✅ New York Exciting conversations about potential collaborations with a hospital in the city that never sleeps. ✅ Washington, DC The support from the British Embassy Washington and Embassy of Switzerland in the United States of America was truly inspiring. Meeting with the Swiss #Ambassador and other advocates of innovation gave us fresh perspectives to refine our go-to-market strategy. The hospitality and encouragement we received were deeply meaningful. A heartfelt thank you to everyone who made this journey so impactful! 🙏 💜 We’re growing, learning, and more determined than ever to bring our innovative solution to the US. 🌟 🚀 Henry Twerenbold, Matteo Cariglia, Emily Reiser, Stewart Tipson, Simone Wyss Fedele, Ralf Heckner, Hannah Freeman, Eleanor Brogden, Alex Bickel, Annina Barbara Bosshard, Irene-Alexandra Katopodis, Jay Manouchehri #Medtech #combatInfections #combatAMR #USUKCH #strongtogether

💥 Aseptuva is delighted to announce that our grant application for the NIHR (National Institute for Health and Care Research) Invention for Innovation (#i4i) Connect - Call 8 has been approved. ✨💪 This project aims to bring our disinfection devices closer to future in-human applications by gathering end-user feedback through Usability Studies to be conducted at Guy's and St Thomas' NHS Foundation Trust's Clinical Skills and Simulation Centre (#CSSC) at Royal Brompton Hospital. 👨⚕️ 👩⚕️ 🏥   Furthermore, we will work with Früh Verpackungstechnik AG 📦 to complete validation studies for suitable packaging solutions and importantly, engage with patients through Patient Public Involvement (#PPI) activities supported by the NIHR HealthTech Research Centre in Brain Injury hosted by Cambridge University Hospitals NHS Foundation Trust 👨⚕️ 👩⚕️. The PPI activities will focus on understanding the challenges faced by patients in the context of hospital acquired infections (#HAI) and create awareness of our technology’s unique value propositions. 💡 🚀 #Medtech #combatAMR #combatInfections #UKUSCH #strongtogether

Recently, Aseptuva had the privilege of joining a fantastic cohort of founders on a journey to #Boston as part of the 2024 Venture Leaders MedTech team. 🌍🌟 Over a packed week filled with pitch sessions, expert insights, and invaluable networking opportunities, the entrepreneurs were sharing and learning from each other’s professional and personal stories. 🚀💡 A heartfelt thank you to Ekaterina K. and Stefan Steiner from Venturelab for orchestrating such an exhilarating program. Our deepest gratitude to Oriane Rütsche and the fantastic teams at Swissnex in Boston and New York for being such welcoming hosts. 🙏 This unforgettable experience wouldn’t have been possible without the incredible support of our sponsors: Isabell Metzler from Kanton Zürich, Max-André Haas from Kellerhals Carrard, Quentin Beaufils from Etat de Vaud, François Capel from Innovaud, Marjan Kraak from Health Innovation Hub Aargau #Medtech #combatInfections #combatAMR #USCHUK #strongtogether

MassChallenge Switzerland was a blast! Two weeks ago the program culminated in a remarkable award ceremony in Lausanne. After 2400 global applications and almost 120 finalists we are humbled to be among the Top-20 winners.🎇   A massive thank you to MassChallenge and their incredible team, led by Matthew Lashmar, for their unwavering support and guidance over the past few months. Special gratitude goes out to the mentors who shared their invaluable expertise in healthcare, regulatory affairs, and business development. 🙏   And on top, it was an honor to meet so many impact-driven entrepreneurs from around the world! 🌍 We look forward to reconnecting and collaborating with you in the future. 🚀 Patrick Pestalozzi Dr Pierre A. Morgon, Philippe Etter Izabela Ławrynowicz Selim Dusi Marc Matthijs Hendrik Marcel Dik Elodie Waquet Yefei Xia Augustin Woronoff Isabella Jespersen Nicolas Meneses David Kinsella #Medtech #combatInfections #combatAMR #UKUSCH #strongtogether

Thrilled to announce that Aseptuva was proudly represented by Alexia and Henry at the 2nd Swiss Translational Medicine Conference in #Bern! ✨ This inspiring event was a platform to showcase our cutting-edge Far-UVC disinfection adaptors, designed to tackle hospital-acquired infections and support the fight against antimicrobial resistance.🏥 We're immensely grateful to Innovate UK and Department for Business and Trade for the opportunity to exhibit alongside other pioneering startups, each making strides toward a healthier future.🙏 The conference united visionary leaders in translational medicine, 👨⚕️ 👩⚕️ spotlighting the journey from groundbreaking research to real-world impact. A huge thank you to sitem-insel AG for orchestrating such an insightful gathering. We’re energized by the shared mission to advance healthcare solutions for society. 🚀 #Medtech #combatInfections #combatAMR #UKCHUS #strongtogether

This Thursday, on the 24th of October, we will be at the 2nd Swiss Translational Medicine conference at sitem-insel AG, Bern. Meet with the Aseptuva team, represented by Henry Twerenbold and Alexia Lamprakaki, at our exhibition booth sponsored by the Department for Business and Trade at the British Embassy in Switzerland. Join us and five other UK companies to learn how #UK #Swiss collaborations advance the fight against #AMR and several pressing global health challenges. 🇨🇭 🇬🇧 ⚕

Aseptuva is amongst the 10 startups selected for the Venture Leaders MedTech cohort of Venturelab, and will tour the Boston area in November as a part of the Swiss National Startup Team. 🚀👨⚕️ Last week’s kick-off session at the #IFJ startup space in Zurich was a fantastic opportunity to meet with the other finalists. Stay tuned for more updates! ✨ #Medtech #combatInfections #combatAMR #USUKCH #strongtogether

Thank you to Venturelab for this incredible opportunity! 🙏 Aseptuva is honored to be part of this outstanding Venture Leaders group of Swiss Medtech innovators. 👩⚕️ 👨⚕️ 🚀   We look forward to the chance to connect with global investors and healthcare leaders in Boston. ✨🌎 #Medtech #combatInfections #combatAMR #strongtogether

We would like to extend our heartfelt congratulations and gratitude to Leon for successfully defending his Master’s Thesis in Medical Sciences at Karolinska Institutet! 🎉 ❤️ We are immensely proud to have supported Leon throughout this important journey. His research on the adoption of infection prevention innovations in U.S. hospitals will be instrumental for our Going-to-Market strategy and to communicate to various stakeholders the value of our innovation. 🏥 🌎 Thank you for your incredible efforts and contributions to Aseptuva. 🚀 🙏 #Medtech #combatInfections #combatAMR #strongtogether

Aseptuva had the amazing opportunity to be part of the #GBIP programme in Singapore for Medtech & Diagnostics along with 15 amazing entrepreneurs 👩⚕️ 👨⚕️ , hosted by Innovate UK and the British High Commission. ✨ 🚪   We had the chance to visit global medtech manufacturers and academic institutions such as National University of Singapore, aiming for our successful expansion into the #ASEAN region. 🏥 🌏   We’d like to thank Trevor Marshall and Maggie C. for their excellent execution. 🙏   Cannot wait for what’s to come, thank you Innovate UK!! 🚀 Alexia Lamprakaki, #AISight, Apnea-Tech Ltd, Aston Vision Sciences Ltd, #BioRejenPrometheus, Cardiology Devices Ltd, Corryn Biotechnologies, Digostics, frequasense, GenoME Diagnostics Ltd, Glyconics Ltd, iLoF, Kerato Limited , Sierra Medical, ZiO Health #Medtech #combatInfections #combatAMR #strongtogether